explore -WSS

explore

author：fashion 2025-09-29 23:28:07 - browse：44887

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： RaDonda Vaught links Vanderbilt hospital issues to patient death

leisure time

WSS

What we owe ALS patients — and why one company fell short

IVG is promising — but it won’t replace IVF quite yet

How to save health care price transparency rules

WuXi out of biotech trade group, U.S. and China relations to blame

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Steward Health Care Massachusetts hospitals face fiscal disaster

knowledge

explore

focus

New air purifier tech could be key to improving indoor air quality

Experts study whether long Covid risk adds up with each reinfection

Dobbs anniversary: the lost opportunity of abortion as health care

How many hemophilia patients actually want gene therapy?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Congress extends some pandemic preparedness programs

Hollywood unions extend contract negotiations for actors

UCLA team creates talking throat patch for voice disorders

Heart attack and stroke risk calculators need revising

How many hemophilia patients actually want gene therapy?

focus

RaDonda Vaught links Vanderbilt hospital issues to patient death

Study points to new risk in gene therapy death of Terry Horgan

HHS secretary Becerra pressed on Change HealthCare cyberattack

How to save health care price transparency rules

Ebola: Gilead Sciences antiviral shows promise as new treatment

RSV injection headlines need to be accurate for good uptake

hotspot

leisure time

entertainment

entertainment